Page last updated: 2024-10-20

pteridines and Nasopharyngeal Carcinoma

pteridines has been researched along with Nasopharyngeal Carcinoma in 1 studies

Nasopharyngeal Carcinoma: A carcinoma that originates in the EPITHELIUM of the NASOPHARYNX and includes four subtypes: keratinizing squamous cell, non-keratinizing, basaloid squamous cell, and PAPILLARY ADENOCARCINOMA. It is most prevalent in Southeast Asian populations and is associated with EPSTEIN-BARR VIRUS INFECTIONS. Somatic mutations associated with this cancer have been identified in NPCR, BAP1, UBAP1, ERBB2, ERBB3, MLL2, PIK3CA, KRAS, NRAS, and ARID1A genes.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Li, J1
Hong, MJ1
Chow, JP1
Man, WY1
Mak, JP1
Ma, HT1
Poon, RY1

Other Studies

1 other study available for pteridines and Nasopharyngeal Carcinoma

ArticleYear
Co-inhibition of polo-like kinase 1 and Aurora kinases promotes mitotic catastrophe.
    Oncotarget, 2015, Apr-20, Volume: 6, Issue:11

    Topics: Animals; Antineoplastic Agents; Aurora Kinase A; Aurora Kinase B; Carcinoma; Cell Cycle Proteins; Cy

2015